Medical Metrics, Inc. (MMI) announces the publication of the 150th scientific report featuring its Quantitative Motion Analysis (QMA®) technology. QMA® is MMI’s proprietary radiographic measurement and image enhancement technology that has been extensively validated and used in numerous clinical and research studies of treatments for spinal disorders. Further, QMA® has also been used in many US-Food and Drug Administration (FDA)-regulated clinical trials studying such treatments and is 510(k)-cleared by the FDA.
The list of scientific publications featuring QMA® spans leading peer-reviewed journals such as Spine, The Spine Journal, SAS Journal, Journal of Spinal Disorders and Techniques, Journal of Neurosurgery: Spine, Journal of Biomechanics, etc. In addition, several posters and podium presentations involving image analysis with QMA® have been made at prestigious scientific fora such as the annual meetings of the North American Spine Society (NASS), Spine Arthroplasty Society (SAS) / International Society for the Advancement of Spine Surgery (ISASS), EuroSpine, Cervical Spine Research Society (CSRS), etc. Some key publications include:
QMA® continues to gain widespread acceptance in pre-clinical, clinical and research applications studying intervertebral motion as evidenced by the growing number of scientific publications. QMA®-derived data have been accepted by the FDA as a part of clinical trials involving motion-preserving devices and fusion treatments, including several “firsts to market”. With measurement accuracy validated to within 0.5 degrees and 0.5 mm, this technology is widely regarded as the “gold standard” for quantitative intervertebral motion analysis.
About Medical Metrics
Medical Metrics, Inc. (MMI) is an experienced, ISO 9001-certified, independent imaging core lab for multi-center clinical trials. Since 2000, MMI has partnered with clinical trial sponsors to conduct comprehensive imaging evaluations of treatments for musculoskeletal, cardiovascular, and neurological disorders. Trials range from pre-clinical and early-phase clinical studies to pivotal trials and post-approval surveillance. With an ISO-certified quality system, experienced project management team, proprietary data management platform, and luminary group of radiology and cardiology thought-leaders, MMI is uniquely positioned to deliver high-quality imaging core lab services for complex clinical trials.